Literature DB >> 17611386

[Pancreatic metastasis of malignant melanoma diagnosed by EUS-guided fine needle aspiration (EUS-FNA)].

Madoka Minoguchi1, Nobuyuki Yanagawa, Chisato Ishikawa, Junpei Sasajima, Mitsuru Goto, Miho Okamoto, Yoshinori Saito, Masanori Murakami, Yutaka Orii, Toru Yaosaka.   

Abstract

Pancreatic metastasis of malignant melanoma is rarely diagnosed while the patient is alive. We report a case of metastatic melanoma of the pancreas in a 35-year-old woman presenting with a solid mass of the pancreas. Her past medical history included a radical hysterectomy 2 years previously for malignant melanoma of the vagina. Twelve months later, lung metastasis was also resected. EUS-guided fine needle aspiration (EUS-FNA) identified that the pancreatic tumor was histologically and immunohistochemically identical to the surgical specimen of her lung neoplasm. Imaging studies including US, CT, and MRI have limited value to distinguish the tumors from primary ductal adenocarcinoma. EUS-FNA can provide tissue diagnosis from pancreatic masses, specifically when other modalities have failed.

Entities:  

Mesh:

Year:  2007        PMID: 17611386

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  3 in total

1.  Endoscopic ultrasound-guided fine-needle aspiration of metastases to the pancreas: A study of 25 cases.

Authors:  Christopher M Gilbert; Sara E Monaco; Scott T Cooper; Walid E Khalbuss
Journal:  Cytojournal       Date:  2011-04-21       Impact factor: 2.091

2.  Multiple pancreatic metastases from malignant melanoma: Conclusive diagnosis with endoscopic ultrasound-guided fine needle aspiration.

Authors:  Tanima Jana; Nancy P Caraway; Atsushi Irisawa; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2015 Apr-Jun       Impact factor: 5.628

3.  Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases.

Authors:  José Celso Ardengh; César Vivian Lopes; Rafael Kemp; Filadélfio Venco; Eder Rios de Lima-Filho; José Sebastião dos Santos
Journal:  BMC Gastroenterol       Date:  2013-04-11       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.